AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Tergra M (50mg+500mg) Tablet

Prescription Icon
Prescription Required

Marketer

Biocon

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Tergra M (50mg+500mg) Tablet

Diabetac Duo (50mg+500mg) tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabetac Duo (50mg+500mg) may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and current medications. Ingesting the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle choices significantly impact blood sugar control. Commonly reported side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia, a potential adverse effect when used with insulin or sulfonylureas, requires awareness and appropriate management strategies. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should consult their doctor before use. Interactions with other medications are possible; therefore, disclose all current medications to ensure safety. Alcohol intake should be limited due to its potential to lower blood sugar. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Tergra M (50mg+500mg) Tablet

No text provided to rephrase.

Uses of Tergra M (50mg+500mg) Tablet

Managing type 2 diabetes

Major Benefits of Tergra M (50mg+500mg) Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Tergra M (50mg+500mg) tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Tergra M (50mg+500mg) Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Tergra M (50mg+500mg) Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Tergra M (50mg+500mg) Tablet should be administered with a meal.

How Tergra M (50mg+500mg) Tablet works:

Tergra M tablets (50mg+500mg) combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Tergra M (50mg+500mg) tablets is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Tergra M (50mg+500mg) tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Tergra M (50mg+500mg) Tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Tergra M (50mg+500mg) tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Tergra M (50mg+500mg) tablets. Physician consultation is essential. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disorders should likely avoid Tergra M (50mg+500mg) tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Tergra M (50mg+500mg) Tablet :

Should you forget to take a Tergra M (50mg+500mg) Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tergra M (50mg+500mg) Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Tergra M (50mg+500mg) Tablet

Tergra M (50mg+500mg) tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Tergra M (50mg+500mg) tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Tergra M (50mg+500mg) Tablets may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Tergra M (50mg+500mg) Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Tergra M (50mg+500mg) tablets is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid, is a potential, though rare, side effect of Tergra M (50mg+500mg) Tablets. Also known as metformin-associated lactic acidosis (MALA), it's more likely in patients with kidney disease, older individuals, or those who consume significant alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Tergra M and seek immediate medical attention.
Tergra M (50mg+500mg) tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Tergra M (50mg+500mg) Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Tergra M (50mg+500mg) Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Tergra M (50mg+500mg) tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Tergra M (50mg+500mg) tablets. This rare complication is more likely in individuals with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms after taking Sitagliptin + Metformin, discontinue use and seek immediate medical attention.
Prolonged use of Tergra M (50mg+500mg) Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Tergra M (50mg+500mg) tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Tergra M (50mg+500mg) Tablets may cause common side effects such as hypoglycemia (low blood sugar), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Tergra M (50mg+500mg) Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Tergra M (50mg+500mg) tablets is unsafe and may raise your risk of lactic acidosis.
Lactic acidosis, a serious medical emergency caused by excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Tergra M (50mg+500mg) tablets. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged use of Tergra M (50mg+500mg) Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Tergra M (50mg+500mg) Tab...
135